Stephen Maxted Ansell, MD, PhD

  • 22276 Citations
  • 80 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
Article

Harnessing the power of the immune system in non-Hodgkin lymphoma: Immunomodulators, checkpoint inhibitors, and beyond

Ansell, S. M., Dec 8 2017, In : Hematology. 2017, 1, p. 618-621 4 p.

Research output: Contribution to journalArticle

4 Scopus citations

High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system

Gill, P., Litzow, M., Buckner, J., Arndt, C., Moynihan, T., Christianson, T., Ansell, S. & Galanis, E., Apr 15 2008, In : Cancer. 112, 8, p. 1805-1811 7 p.

Research output: Contribution to journalArticle

18 Scopus citations

Hodgkin lymphoma: Diagnosis and treatment

Ansell, S. M., 2015, In : Mayo Clinic Proceedings. 90, 11, p. 1574-1583 10 p.

Research output: Contribution to journalArticle

50 Scopus citations

Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management

Ansell, S. M., Jul 2014, In : American journal of hematology. 89, 7, p. 771-779 9 p.

Research output: Contribution to journalArticle

19 Scopus citations

Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management

Ansell, S. M., Dec 1 2012, In : American journal of hematology. 87, 12, p. 1096-1103 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond

Ansell, S. M., Jan 1 2016, In : American Journal of Hematology. 91, 1, p. 109-112 4 p.

Research output: Contribution to journalArticle

10 Scopus citations

Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management

Ansell, S. M., Apr 1 2016, In : American Journal of Hematology. 91, 4, p. 434-442 9 p.

Research output: Contribution to journalArticle

52 Scopus citations

Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management

Ansell, S. M., May 1 2018, In : American Journal of Hematology. 93, 5, p. 704-715 12 p.

Research output: Contribution to journalArticle

13 Scopus citations

Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia

Cerhan, J. R., Vachon, C. M., Habermann, T. M., Ansell, S. M., Witzig, T. E., Kurtin, P. J., Janney, C. A., Zheng, W., Potter, J. D., Sellers, T. A. & Folsom, A. R., Nov 1 2002, In : Cancer Epidemiology Biomarkers and Prevention. 11, 11, p. 1466-1471 6 p.

Research output: Contribution to journalArticle

43 Scopus citations

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era

Habermann, T. M., Wang, S. S., Maurer, M. J., Morton, L. M., Lynch, C. F., Ansell, S. M., Hartge, P., Severson, R. K., Rothman, N., Davis, S., Geyer, S. M., Cozen, W., Chanock, S. J. & Cerhan, J. R., Oct 1 2008, In : Blood. 112, 7, p. 2694-2702 9 p.

Research output: Contribution to journalArticle

58 Scopus citations

How to select the frontline treatment for a patient with peripheral T-cell lymphoma

Ansell, S. M., Apr 2 2016, In : Leukemia and Lymphoma. 57, 4, p. 783-788 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Human Pegivirus infection and lymphoma risk and prognosis: A North American study

Fama, A., Xiang, J., Link, B. K., Allmer, C., Klinzman, D., Feldman, A. L., Nowakowski, G. S., Liebow, M., Larson, M. C., Maurer, M. J., Ansell, S. M., Novak, A. J., Asmann, Y., Slager, S. L., Call, T. G., Habermann, T. M., Cerhan, J. R. & Stapleton, J. T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

9 Scopus citations

Ibrutinib for the treatment of Bing-Neel syndrome: A multicenter study

Castillo, J. J., Itchaki, G., Paludo, J., Varettoni, M., Buske, C., Eyre, T. A., Chavez, J. C., Shain, K. H., Issa, S., Palomba, M. L., Pasvolsky, O., Simpson, D., Talaulikar, D., Tam, C. S., Tedeschi, A., Ansell, S. M., Nayak, L. & Treon, S. P., Jan 24 2019, In : Blood. 133, 4, p. 299-305 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

Ibrutinib for the treatment of Waldenström macroglobulinemia

Chakraborty, R., Kapoor, P., Ansell, S. M. & Gertz, M., Sep 3 2015, In : Expert Review of Hematology. 8, 5, p. 569-579 11 p.

Research output: Contribution to journalArticle

10 Scopus citations
2 Scopus citations

Ifosfamide in advanced carcinoma of the esophagus: A phase II trial with severe toxicity

Ansell, S. M., Alberts, A. S. & Falkson, G., Jan 1 1989, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 12, 3, p. 205-207 3 p.

Research output: Contribution to journalArticle

10 Scopus citations

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

Sidana, S., Larson, D. P., Greipp, P. T., He, R., McPhail, E. D., Dispenzieri, A., Murray, D. L., Dasari, S., Ansell, S. M., Muchtar, E., Gonsalves, W. I., Kourelis, T. V., Ramirez-Alvarado, M., Kapoor, P., Rajkumar, S. V., Lacy, M. Q., Buadi, F. K., Leung, N., Kyle, R. A., Kumar, S. K. & 2 others, King, R. L. & Gertz, M. A., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Aspitia, A. M., Ansell, S., Kyle, R. & Mikhael, J., Nov 1 2010, In : American journal of hematology. 85, 11, p. 853-855 3 p.

Research output: Contribution to journalArticle

52 Scopus citations

IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma

Xiu, B., Lin, Y., Grote, D. M., Ziesmer, S. C., Gustafson, M., Maas, M. L., Zhang, Z., Dietz, A. B., Porrata, L. F., Novak, A. J., Liang, A. B., Yang, Z. Z. & Ansell, S. M., Jul 31 2015, In : Blood Cancer Journal. 5, 7, e328.

Research output: Contribution to journalArticle

33 Scopus citations

IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma

Yang, Z. Z., Grote, D. M., Ziesmer, S. C., Niki, T., Hirashima, M., Novak, A. J., Witzig, T. E. & Ansell, S. M., Apr 2 2012, In : Journal of Clinical Investigation. 122, 4, p. 1271-1282 12 p.

Research output: Contribution to journalArticle

150 Scopus citations

IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia

Hodge, L. S., Ziesmer, S. C., Yang, Z. Z., Secreto, F. J., Gertz, M. A., Novak, A. J. & Ansell, S. M., Nov 1 2012, In : Blood. 120, 18, p. 3774-3782 9 p.

Research output: Contribution to journalArticle

25 Scopus citations

Illicit intravenous drug use in Johannesburg - Medical complications and prevalence of HIV infection

Williams, P. G., Ansell, S. M. & Milne, F. J., Sep 16 1997, In : South African Medical Journal. 87, 7, p. 889-891 3 p.

Research output: Contribution to journalArticle

13 Scopus citations

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma

Porrata, L. F., Burgstaler, E. A., Winters, J. L., Jacob, E. K., Gastineau, D. A., Suman, V. J., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Nevala, W. & Markovic, S. N., Sep 23 2015, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

7 Scopus citations

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Houot, R., Gaulard, P., Schreiber, R., Mellman, I., Lambotte, O., Coulie, P. G., Fest, T., Korman, A., Levy, R., Shipp, M., Tarte, K., Kohrt, H., Marabelle, A., Ansell, S. M., Watier, H., van Elsas, A., Balakumaran, A., Arce Vargas, F., Quezada, S. A., Salles, G. & 1 others, Olive, D., Jul 2 2016, In : OncoImmunology. 5, 7, e1186323.

Research output: Contribution to journalArticle

2 Scopus citations

Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?

Ansell, S. M., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Immunotherapy in lymphoma

Ansell, S. M., Caligaris-Cappio, F. & Maloney, D. G., Jun 1 2017, In : Hematological Oncology. 35, p. 88-91 4 p.

Research output: Contribution to journalArticle

1 Scopus citations

Immunotransplant: Preventing unintended consequences

Ansell, S. M., Nov 2019, In : Cancer discovery. 9, 11, p. 1487-1489 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

Wang, Y., Link, B. K., Witzig, T. E., Maurer, M. J., Allmer, C., King, R. L., Feldman, A. L., Habermann, T. M., Ansell, S. M., Slager, S. L., Cerhan, J. R. & Nowakowski, G. S., Oct 17 2019, In : Blood. 134, 16, p. 1289-1297 9 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma

Wang, Y., Maurer, M. J., Larson, M. C., Allmer, C., Feldman, A. L., Bennani, N., Thompson, C. A., Porrata, L. F., Habermann, T. M., Witzig, T. E., Ansell, S. M., Slager, S. L., Nowakowski, G. S. & Cerhan, J. R., Sep 1 2019, In : British journal of haematology. 186, 6, p. 820-828 9 p.

Research output: Contribution to journalArticle

Incidence of Supraventricular Arrhythmias during Autologous peripheral blood stem cell transplantation

Singla, A., Hogan, W. J., Ansell, S. M., Buadi, F. K., Dingli, D., Dispenzieri, A., Gastineau, D. A., Gertz, M. A., Hayman, S. R., Inwards, D. J., Johnston, P. B., Lacy, M. Q., Litzow, M. R., Micallef, I. N., Porrata, L. F. & Kumar, S. K., Aug 1 2013, In : Biology of Blood and Marrow Transplantation. 19, 8, p. 1233-1237 5 p.

Research output: Contribution to journalArticle

16 Scopus citations

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

McPhail, E., Maurer, M. J., Macon, W. R., Feldman, A. L., Kurtin, P. J., Ketterling, R. P., Vaidya, R., Cerhan, J. R., Ansell, S. M., Porrata, L. F., Nowakowski, G. S., Witzig, T. E. & Habermann, T. M., Nov 1 2018, In : Haematologica. 103, 11, p. 1899-1907 9 p.

Research output: Contribution to journalArticle

14 Scopus citations

Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I. N., Johnston, P. B., Hogan, W. J. & Markovic, S. N., Nov 1 2014, In : Biology of Blood and Marrow Transplantation. 20, 11, p. 1804-1812 9 p.

Research output: Contribution to journalArticle

16 Scopus citations
3 Scopus citations

Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Hogan, W. & Markovic, S. N., Feb 2 2015, In : Journal of Blood Medicine. 6, p. 45-53 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma

Porrata, L. F., Lotzow, M. R., Inwards, D. J., Gastineau, D. A., Moore, S. B., Pineda, A. A., Bundy, K. L., Padley, D. J., Persky, D., Ansell, S. M., Micaleef, I. N. M. & Markovic, S. N., Feb 1 2004, In : Bone Marrow Transplantation. 33, 3, p. 291-298 8 p.

Research output: Contribution to journalArticle

78 Scopus citations
3 Scopus citations

Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides

Price-Troska, T., Yang, Z. Z., Diller, D., Bayden, A., Jarosinski, M., Audie, J. & Ansell, S. M., Apr 26 2018, (Accepted/In press) In : Investigational New Drugs. p. 1-8 8 p.

Research output: Contribution to journalArticle

126 Scopus citations

Inihibitor of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma

Ansell, S. M., Arendt, B. K., Grote, D. M., Jelinek, D. F., Novak, A. J., Wellik, L. E., Remstein, E. D., Bennett, C. F. & Fielding, A., Mar 2004, In : Leukemia. 18, 3, p. 616-623 8 p.

Research output: Contribution to journalArticle

83 Scopus citations

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

Luchtel, R., Razidlo, G., Dasari, S., Zeng, Y., Hu, G., Knudson, R. A., Greipp, P. T., Davila, J. I., Johnson, S. H., Porcher, J. C., Smadbeck, J., Eckloff, B. W., Billadeau, D. D., Kurtin, P. J., Mc Niven, M. A., Link, B. K., Ansell, S. M., Cerhan, J. R., Asmann, Y., Vasmatzis, G. & 1 others, Feldman, A. L., Sep 1 2016, In : Blood. 128, 9, p. 1234-1245 12 p.

Research output: Contribution to journalArticle

47 Scopus citations

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

Herrera, A. F., Moskowitz, A. J., Bartlett, N. L., Vose, J. M., Ramchandren, R., Feldman, T. A., LaCasce, A. S., Ansell, S. M., Moskowitz, C. H., Fenton, K., Ogden, C. A., Taft, D., Zhang, Q., Kato, K., Campbell, M. & Advani, R. H., Mar 15 2018, In : Blood. 131, 11, p. 1183-1194 12 p.

Research output: Contribution to journalArticle

87 Scopus citations
15 Scopus citations

Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells

Arendt, B. K., Velazquez-Dones, A., Tschumper, R. C., Howell, K. G., Ansell, S. M., Witzig, T. E. & Jelinek, D. F., Jan 1 2002, In : Leukemia. 16, 10, p. 2142-2147 6 p.

Research output: Contribution to journalArticle

33 Scopus citations

International assessment of event-free survival at 24 months and subsequent survival in peripheral T-cell lymphoma

Maurer, M. J., Ellin, F., Srour, L., Jerkeman, M., Bennani, N., Connors, J. M., Slack, G. W., Smedby, K. E., Ansell, S. M., Link, B. K., Cerhan, J. R., Relander, T., Savage, K. J. & Feldman, A. L., Dec 20 2017, In : Journal of Clinical Oncology. 35, 36, p. 4019-4026 8 p.

Research output: Contribution to journalArticle

14 Scopus citations

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

Younes, A., Hilden, P., Coiffier, B., Hagenbeek, A., Salles, G., Wilson, W., Seymour, J. F., Kelly, K., Gribben, J., Pfreunschuh, M., Morschhauser, F., Schoder, H., Zelenetz, A. D., Rademaker, J., Advani, R., Valente, N., Fortpied, C., Witzig, T. E., Sehn, L. H., Engert, A. & 30 others, Fisher, R. I., Zinzani, P. L., Federico, M., Hutchings, M., Bollard, C., Trneny, M., Elsayed, Y. A., Tobinai, K., Abramson, J. S., Fowler, N., Goy, A., Smith, M., Ansell, S. M., Kuruvilla, J., Dreyling, M., Thieblemont, C., Little, R. F., Aurer, I., Van Oers, M. H. J., Takeshita, K., Gopal, A., Rule, S., de Vos, S., Kloos, I., Kaminski, M. S., Meignan, M., Schwartz, L. H., Leonard, J. P., Schuster, S. J. & Seshan, V. E., Jul 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 7, p. 1436-1447 12 p.

Research output: Contribution to journalArticle

54 Scopus citations

Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma

Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R. & Sargent, D. J., Oct 2009, In : Gastroenterology. 137, 4, p. 1270-1279 10 p.

Research output: Contribution to journalArticle

186 Scopus citations

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

Yang, Z. Z., Novak, A. J., Stenson, M. J., Witzig, T. E. & Ansell, S. M., May 1 2006, In : Blood. 107, 9, p. 3639-3646 8 p.

Research output: Contribution to journalArticle

332 Scopus citations

Jak/stat pathway in Waldenström's macroglobulinemia

Hodge, L. S. & Ansell, S. M., Feb 1 2011, In : Clinical Lymphoma, Myeloma and Leukemia. 11, 1, p. 112-114 3 p.

Research output: Contribution to journalArticle

13 Scopus citations
9 Scopus citations